Repair of Incompetent Heart Valves by Interstitial Implantation of Space Occupying Materials or Devices

• US 20080249618A1
• Filed: 08/13/2007
• Published: 10/09/2008
• Est. Priority Date: 04/09/2007
• Status: Abandoned Application

• Current Assignee: Medtronic Vascular, Inc. (Medtronic Plc)
• Original Assignee: Medtronic Vascular, Inc. (Medtronic Plc)
• Inventors: Huynh, Rany, Lamson, Theodore
• Application Number:
  US11/837,706
• Publication Number:
  US 20080249618A1
• Time in Patent Office: Days
• US Class Current: 623/2.11
• CPC Class Codes: A61F 2/2442 Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
• CPC Class Codes: A61F 2/2451 Inserts in the coronary sinus for correcting the valve shape
• CPC Class Codes: A61F 2002/249 Device completely embedded in the heart wall
• CPC Class Codes: A61F 2210/0004 bioabsorbable

Abstract

Incompetency or regurgitation of a cardiac valve is treated by injecting a space occupying material(s) or implanting a space occupying device(s) at an interstitial location adjacent to the valve such that the space occupying material or device exerts pressure on the valve causing one or more leaflets of the valve to be favorably repositioned. The procedure may be performed by open thoracotomy, thorascopically or transluminally using a tissue penetrating catheter.

Claims

1. A method for improving function of an incompetent cardiac valve that has leaflets, said method comprising the step of:

A) implanting a space occupier at an interstitial location(s) within heart tissue such that force exerted by the space occupier causes repositioning of at least one of the valve leaflets to improve competency of the valve.

2. A method according to claim 1 wherein the space occupier comprises a quantity of space occupying substance and wherein Step A comprises delivering said space occupying substance to the interstitial location within heart tissue.

3. A method according to claim 2 wherein the space occupying material is injectable through the lumen of an delivery cannula and wherein Step A comprises:

i) inserting an delivery cannula into the heart; and

ii) injecting the space occupying material through the delivery cannula to form a depot of the space occupying material at the interstitial location within heart tissue.

4. A method according to claim 3 wherein the delivery cannula comprises a needle having one or more lumens.

5. A method according to claim 3 wherein the delivery cannula is advanceable from a tissue penetrating catheter and wherein the step of inserting the delivery cannula into the heart comprises:

inserting the tissue penetrating catheter into the subject'"'"'s vasculature;

advancing the tissue penetrating catheter through the subject'"'"'s vasculature to a location within the coronary vasculature;

advancing the delivery cannula from the tissue penetrating catheter and into cardiac tissue; and

injecting the space occupying material through the delivery cannula to form a depot of the space occupying material at the interstitial location within heart tissue.

6. A method according to claim 5 wherein the delivery cannula is part of the tissue penetrating catheter.

7. A method according to claim 6 wherein the tissue penetrating catheter has a tissue penetrator that has a lumen and an open distal end, said tissue penetrator being advanceable from the tissue penetrating catheter into the cardiac tissue, and wherein:

the step of advancing the delivery cannula from the tissue penetrating catheter and into cardiac tissue comprises i) advancing the tissue penetrator from the tissue penetrating catheter into cardiac tissue and ii) advancing the delivery cannula through the lumen of the tissue penetrator and out of its open distal end.

8. A method according claim 7 wherein the delivery cannula comprises a flexible catheter.

9. A method according to claim 8 wherein the delivery cannula has a tissue penetrating distal end so that it may penetrate further through cardiac tissue after exiting the distal end opening of the tissue penetrator.

10. A method according to claim 5 wherein the tissue penetrating catheter is equipped with orientation apparatus useable to determine the trajectory on which the delivery cannula will advance and wherein the method further comprises the steps of:

using the orientation apparatus to determine a projected trajectory on which the delivery cannula will advance; and

adjusting the rotational orientation of the catheter as needed so that the projected trajectory on which the delivery cannula will advance is in the direction of the intended implantation location.

11. A method according to claim 7 wherein the tissue penetrating catheter is equipped with orientation apparatus useable to determine the trajectory on which the tissue penetrator will advance and wherein the method further comprises the steps of:

using the orientation apparatus to determine a projected trajectory on which the tissue penetrator will advance; and

adjusting the rotational orientation of the catheter as needed so that the projected trajectory on which the tissue penetrator will advance is in the direction of the intended implantation location.

12. A method according to claim 5 wherein the tissue penetrating catheter is inserted into the subject'"'"'s venous vasculature and advanced into the coronary sinus or a coronary vein of the subject'"'"'s heart.

13. A method according to claim 5 wherein the tissue penetrating catheter is inserted into the subject'"'"'s arterial vasculature and advanced into a coronary artery.

14. A method according to claim 2 wherein the space occupying substance is selected from the group consisting of:

A) collagens;

B) hyaluronic acid;

C) polymeric materials; and

D) hydrogels.

15. A method according to claim 2 wherein the space occupying substance expands after it has been delivered to the interstitial location within heart tissue.

16. A method according to claim 1 wherein the space occupier comprises a space occupying device.

17. A method according to claim 16 wherein the space occupying device is selected from the group consisting of beads, balls, filaments, stents, cages, expandable structures, implantable balloons, implantable balloons filled with solid or gellatenous material and implantable tissue expanders.

18. A method according to claim 16 wherein the space occupying device is expandable from a non-expanded configuration to an expanded configuration and wherein the method comprises:

i) advancing the space occupying device to the interstitial location within heart tissue while in its non-expanded configuration; and

ii) causing the space occupying device to expand to its expanded configuration.

19. A method according to claim 18 wherein the space occupying device self-expands and wherein constraint is applied to the space occupying device so that it is constrained in a non-expanded configuration while being delivered to the implantation location and, thereafter, the constraint is removed to allow the space occupying device to self-expand to an expanded configuration.

20. A method according to claim 18 wherein the space occupying device is plastically deformable to its expanded configuration and wherein the space occupying device is delivered to the interstitial location within heart tissue while in its non-expanded configuration and is thereafter plastically deformed to its expanded configuration.

21. A method according to claim 20 wherein the space occupying device is delivered by a delivery catheter that has a balloon, and wherein, during delivery of the space occupying device to the implantation location, the balloon is deflated and the space occupying device is mounted on the deflated balloon and, thereafter, the balloon is inflated thereby causing the space occupying device to expand to its non-expanded configuration.